China Viral Vaccines Industry Research and Trends Report 2021-2027

1 Introduction to Research & Analysis Reports

　1.1 Viral Vaccines Market Definition

　1.2 Market Segments

　　1.2.1 Segment by Type

　　1.2.2 Segment by Application

　1.3 China Viral Vaccines Market Overview

　1.4 Methodology & Sources of Information

　　1.4.1 Research Methodology

　　1.4.2 Research Process

　　1.4.3 Base Year

2 China Viral Vaccines Overall Market Size

　2.1 China Viral Vaccines Market Size: 2021 VS 2027

　2.2 China Viral Vaccines Revenue, Prospects & Forecasts: 2016-2027

　2.3 China Viral Vaccines Sales: 2016-2027

3 Company Landscape

　3.1 Top Viral Vaccines Players in China Market

　3.2 Top China Viral Vaccines Companies Ranked by Revenue

　3.3 China Viral Vaccines Revenue by Companies

　3.4 China Viral Vaccines Sales by Companies

　3.5 China Viral Vaccines Price by Manufacturer (2016-2021)

　3.6 Top 3 and Top 5 Viral Vaccines Companies in China Market, by Revenue in 2020

　3.7 Manufacturers Viral Vaccines Product Type

　3.8 Tier 1, Tier 2 and Tier 3 Viral Vaccines Players in China Market

　　3.8.1 List of Tier 1 Viral Vaccines Companies in China

　　3.8.2 List of Tier 2 and Tier 3 Viral Vaccines Companies in China

轉-自：http://www.5269660.cn/5/69/China-Viral-Vaccines-Industry-Research-and-Trends-Report-2021-2027.html

4 Sights by Type

　4.1 Overview

　　4.1.1 By Type - China Viral Vaccines Market Size Markets, 2021 & 2027

　　4.1.2 Attenuated Vaccine

　　4.1.3 Inactivated Vaccine

　4.2 By Type - China Viral Vaccines Revenue & Forecasts

　　4.2.1 By Type - China Viral Vaccines Revenue, 2016-2021

　　4.2.2 By Type - China Viral Vaccines Revenue, 2022-2027

　　4.2.3 By Type - China Viral Vaccines Revenue Market Share, 2016-2027

　4.3 By Type - China Viral Vaccines Sales & Forecasts

　　4.3.1 By Type - China Viral Vaccines Sales, 2016-2021

　　4.3.2 By Type - China Viral Vaccines Sales, 2022-2027

　　4.3.3 By Type - China Viral Vaccines Sales Market Share, 2016-2027

　4.4 By Type - China Viral Vaccines Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

　5.1 Overview

　　5.1.1 By Application - China Viral Vaccines Market Size, 2021 & 2027

　　5.1.2 Hospital

　　5.1.3 Pharmaceutical Factory

　　5.1.4 Research Institute

　　5.1.5 Others

　5.2 By Application - China Viral Vaccines Revenue & Forecasts

　　5.2.1 By Application - China Viral Vaccines Revenue, 2016-2021

　　5.2.2 By Application - China Viral Vaccines Revenue, 2022-2027

　　5.2.3 By Application - China Viral Vaccines Revenue Market Share, 2016-2027

　5.3 By Application - China Viral Vaccines Sales & Forecasts

　　5.3.1 By Application - China Viral Vaccines Sales, 2016-2021

　　5.3.2 By Application - China Viral Vaccines Sales, 2022-2027

　　5.3.3 By Application - China Viral Vaccines Sales Market Share, 2016-2027

　5.4 By Application - China Viral Vaccines Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

　6.1 GSK

　　6.1.1 GSK Corporation Information

　　6.1.2 GSK Overview

　　6.1.3 GSK Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.1.4 GSK Viral Vaccines Product Description

　　6.1.5 GSK Recent Developments

　6.2 Merck

　　6.2.1 Merck Corporation Information

　　6.2.2 Merck Overview

　　6.2.3 Merck Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.2.4 Merck Viral Vaccines Product Description

　　6.2.5 Merck Recent Developments

　6.3 Novartis

　　6.3.1 Novartis Corporation Information

　　6.3.2 Novartis Overview

　　6.3.3 Novartis Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.3.4 Novartis Viral Vaccines Product Description

　　6.3.5 Novartis Recent Developments

　6.4 Pfizer

　　6.4.1 Pfizer Corporation Information

中國病毒疫苗行業研究與趨勢報告2021-2027

　　6.4.2 Pfizer Overview

　　6.4.3 Pfizer Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.4.4 Pfizer Viral Vaccines Product Description

　　6.4.5 Pfizer Recent Developments

　6.5 Sanofi

　　6.5.1 Sanofi Corporation Information

　　6.5.2 Sanofi Overview

　　6.5.3 Sanofi Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.5.4 Sanofi Viral Vaccines Product Description

　　6.5.5 Sanofi Recent Developments

　6.6 Bayer

　　6.6.1 Bayer Corporation Information

　　6.6.2 Bayer Overview

　　6.6.3 Bayer Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.6.4 Bayer Viral Vaccines Product Description

　　6.6.5 Bayer Recent Developments

　6.7 Zoetis

　　6.7.1 Zoetis Corporation Information

　　6.7.2 Zoetis Overview

　　6.7.3 Zoetis Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.7.4 Zoetis Viral Vaccines Product Description

　　6.7.5 Zoetis Recent Developments

　6.8 AstraZeneca

　　6.8.1 AstraZeneca Corporation Information

　　6.8.2 AstraZeneca Overview

　　6.8.3 AstraZeneca Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.8.4 AstraZeneca Viral Vaccines Product Description

　　6.8.5 AstraZeneca Recent Developments

　6.9 Johnson

　　6.9.1 Johnson Corporation Information

　　6.9.2 Johnson Overview

　　6.9.3 Johnson Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.9.4 Johnson Viral Vaccines Product Description

　　6.9.5 Johnson Recent Developments

　6.10 CSL

　　6.10.1 CSL Corporation Information

　　6.10.2 CSL Overview

　　6.10.3 CSL Viral Vaccines Sales and Revenue in China Market (2016-2021)

　　6.10.4 CSL Viral Vaccines Product Description

　　6.10.5 CSL Recent Developments

7 China Viral Vaccines Production Capacity, Analysis

　7.1 China Viral Vaccines Production Capacity, 2016-2027

　7.2 Viral Vaccines Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

　8.1 Market Opportunities & Trends

　8.2 Market Drivers

　8.3 Market Restraints

9 Viral Vaccines Supply Chain Analysis

　9.1 Viral Vaccines Industry Value Chain

　9.2 Viral Vaccines Upstream Market

　9.3 Viral Vaccines Downstream and Clients

中國病毒疫苗行業研究與趨勢報告2021-2027

　9.4 Marketing Channels Analysis

　　9.4.1 Marketing Channels

　　9.4.2 Viral Vaccines Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

　11.1 Note

　11.2 Examples of Clients

　11.3 Author Details

　11.4 Disclaimer

List of Tables

　Table 1. Key Players of Viral Vaccines in China Market

　Table 2. Top Viral Vaccines Players in China Market, Ranking by Revenue (2019)

　Table 3. China Viral Vaccines Revenue by Companies, (US$, Mn), 2016-2021

　Table 4. China Viral Vaccines Revenue Share by Companies, 2016-2021

　Table 5. China Viral Vaccines Sales by Companies, (K MT), 2016-2021

　Table 6. China Viral Vaccines Sales Share by Companies, 2016-2021

　Table 7. Key Manufacturers Viral Vaccines Price (2016-2021) & (USD/MT)

　Table 8. Manufacturers Viral Vaccines Product Type

　Table 9. List of Tier 1 Viral Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 10. List of Tier 2 and Tier 3 Viral Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 11. Major Manufacturers of Attenuated Vaccine

　Table 12. Major Manufacturers of Inactivated Vaccine

　Table 13. By Type – China Viral Vaccines Revenue, (US$, Mn), 2021 & 2027

　Table 14. By Type - China Viral Vaccines Revenue (US$, Mn), 2016-2021

　Table 15. By Type - China Viral Vaccines Revenue (US$, Mn), 2022-2027

　Table 16. By Type - China Viral Vaccines Sales (K MT), 2016-2021

　Table 17. By Type - China Viral Vaccines Sales (K MT), 2022-2027

　Table 18. By Application – China Viral Vaccines Revenue, (US$, Mn), 2021 VS 2027

　Table 19. By Application - China Viral Vaccines Revenue (US$, Mn), 2016-2021

　Table 20. By Application - China Viral Vaccines Revenue (US$, Mn), 2022-2027

　Table 21. By Application - China Viral Vaccines Sales (K MT), 2016-2021

　Table 22. By Application - China Viral Vaccines Sales (K MT), 2022-2027

　Table 23. GSK Corporation Information

　Table 24. GSK Description and Major Businesses

　Table 25. GSK Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 26. GSK Viral Vaccines Product

　Table 27. GSK Recent Developments

　Table 28. Merck Corporation Information

　Table 29. Merck Description and Major Businesses

　Table 30. Merck Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 31. Merck Viral Vaccines Product

　Table 32. Merck Recent Developments

　Table 33. Novartis Corporation Information

　Table 34. Novartis Description and Major Businesses

　Table 35. Novartis Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 36. Novartis Viral Vaccines Product

　Table 37. Novartis Recent Developments

　Table 38. Pfizer Corporation Information

zhōngguó bìngdú yìmiáo hángyè yánjiū yǔ qūshì bàogào 2021-2027

　Table 39. Pfizer Description and Major Businesses

　Table 40. Pfizer Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 41. Pfizer Viral Vaccines Product

　Table 42. Pfizer Recent Developments

　Table 43. Sanofi Corporation Information

　Table 44. Sanofi Description and Major Businesses

　Table 45. Sanofi Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 46. Sanofi Viral Vaccines Product

　Table 47. Sanofi Recent Developments

　Table 48. Bayer Corporation Information

　Table 49. Bayer Description and Major Businesses

　Table 50. Bayer Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 51. Bayer Viral Vaccines Product

　Table 52. Bayer Recent Developments

　Table 53. Zoetis Corporation Information

　Table 54. Zoetis Description and Major Businesses

　Table 55. Zoetis Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 56. Zoetis Viral Vaccines Product

　Table 57. Zoetis Recent Developments

　Table 58. AstraZeneca Corporation Information

　Table 59. AstraZeneca Description and Major Businesses

　Table 60. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 61. AstraZeneca Viral Vaccines Product

　Table 62. AstraZeneca Recent Developments

　Table 63. Johnson Corporation Information

　Table 64. Johnson Description and Major Businesses

　Table 65. Johnson Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 66. Johnson Viral Vaccines Product

　Table 67. Johnson Recent Developments

　Table 68. CSL Corporation Information

　Table 69. CSL Description and Major Businesses

　Table 70. CSL Viral Vaccines Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 71. CSL Viral Vaccines Product

　Table 72. CSL Recent Developments

　Table 73. Viral Vaccines Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)

　Table 74. China Viral Vaccines Capacity Market Share of Key Manufacturers, 2019-2021

　Table 75. Viral Vaccines Market Opportunities & Trends in China Market

　Table 76. Viral Vaccines Market Drivers in China Market

　Table 77. Viral Vaccines Market Restraints in China Market

　Table 78. Viral Vaccines Raw Materials

　Table 79. Viral Vaccines Raw Materials Suppliers in China Market

　Table 80. Typical Viral Vaccines Downstream

　Table 81. Viral Vaccines Downstream Clients in China Market

　Table 82. Viral Vaccines Distributors and Sales Agents in China Market

List of Figures

　Figure 1. Viral Vaccines Product Picture

　Figure 2. Viral Vaccines Segment by Type

　Figure 3. Viral Vaccines Segment by Application

　Figure 4. China Viral Vaccines Market Overview: 2020

　Figure 5. China Viral Vaccines Market Size: 2021 VS 2027 (US$, Mn)

中國ウイルスワクチン産業研究とトレンド2021-2027

　Figure 6. China Viral Vaccines Revenue, 2016-2027 (US$, Mn)

　Figure 7. Viral Vaccines Sales in China Market: 2016-2027 (K MT)

　Figure 8. The Top 3 and 5 Players Market Share by Viral Vaccines Revenue in 2020

　Figure 9. Attenuated Vaccine Product Picture

　Figure 10. Inactivated Vaccine Product Picture

　Figure 11. By Type - China Viral Vaccines Sales Market Share, 2016-2027

　Figure 12. By Type - China Viral Vaccines Revenue Market Share, 2016-2027

　Figure 13. By Type - China Viral Vaccines Price (USD/MT), 2016-2027

　Figure 14. Hospital

　Figure 15. Pharmaceutical Factory

　Figure 16. Research Institute

　Figure 17. Others

　Figure 18. By Application - China Viral Vaccines Sales Market Share, 2016-2027

　Figure 19. By Application - China Viral Vaccines Revenue Market Share, 2016-2027

　Figure 20. By Application - China Viral Vaccines Price (USD/MT), 2016-2027

　Figure 21. GSK Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 22. Merck Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 23. Novartis Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 24. Pfizer Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 25. Sanofi Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 26. Bayer Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 27. Zoetis Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 28. AstraZeneca Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 29. Johnson Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 30. CSL Viral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 31. China Viral Vaccines Production Capacity (K MT), 2016-2027

　Figure 32. Viral Vaccines Industry Value Chain

　Figure 33. Marketing Channels

　　http://www.5269660.cn/5/69/China-Viral-Vaccines-Industry-Research-and-Trends-Report-2021-2027.html

　　……